A lawsuit out of Amarillo, Texas, could potentially reverse the Food and Drug Administration’s (FDA) approval of mifepristone and misoprostol for use in chemical abortions in the coming weeks.
The Alliance Defending Freedom (ADF) sued the FDA in November on behalf of four medical organizations, arguing that the agency approved the drugs in 2000 without studying their safety under the labeled conditions of use.
The lawsuit claims the FDA ignored evidence that the drugs cause more complications than surgical abortions and ignored their potential physical impacts on adolescent girls.
A decision could come as early as March, an ADF spokesman told the Daily Caller News Foundation, and The Washington Post predicted a decision as soon as next week.
U.S. District Court Judge Matthew Kacsmaryk, appointed by former President Donald Trump, is ruling in this case, and an appeal of his decision would land the case in the conservative-leaning Fifth Circuit Court of Appeals, leading abortion proponents to fear that ADF will win their case and reverse the FDA’s approval, according to the Post. A further appeal could bring the case to the Supreme Court.
Abortion pills make up a massive segment of the abortion industry; the drugs account for 53% of abortions in the U.S., according to the Guttmacher Institute, and banning them would leave women seeking abortions to pursue surgical abortions, which the ADF and some pro-life advocates argue are safer. In states where abortion is heavily restricted, some women obtain medication abortions through providers in other states or even other countries.
Get more information on this story HERE >>>
PureTalk – Save Big Money On Your Cell Phone Bill (Use Promo”FLS” to get 50% off your first month)
Announcing MyPillow 2.0
Brand-new temperature-regulating technology keeps you comfortable throughout the night!